Public Profile

Stallergenes Greer Ltd

Stallergenes Greer Ltd, a leading player in the immunotherapy industry, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 2014 through the merger of Stallergenes and Greer Laboratories, the company has quickly established itself as a pioneer in allergy treatment solutions. Specialising in allergen immunotherapy, Stallergenes Greer offers a range of innovative products, including sublingual and injectable therapies, designed to provide long-term relief from allergic conditions. Their commitment to research and development has led to significant advancements in personalised treatment options, setting them apart in a competitive market. With a strong focus on patient-centric care, Stallergenes Greer Ltd has achieved notable recognition for its contributions to allergy management, solidifying its position as a trusted name in the field.

DitchCarbon Score

How does Stallergenes Greer Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Stallergenes Greer Ltd's score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

84%

Stallergenes Greer Ltd's reported carbon emissions

Stallergenes Greer Ltd, headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company is likely aware of the growing importance of sustainability in the pharmaceutical industry and may be exploring strategies to address carbon emissions in line with industry standards. As climate commitments evolve, it will be essential for Stallergenes Greer Ltd to establish measurable targets and transparent reporting to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Stallergenes Greer Ltd's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Stallergenes Greer Ltd is headquartered in GB, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Stallergenes Greer Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Alk

DK
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Vimian

SE
Health and social work services (85)
Updated 3 days ago

Heska Corporation

US
Health and social work services (85)
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers